Recurrent T lymphoblastic lymphoma

Clinical trials for Recurrent T lymphoblastic lymphoma explained in plain language.

Never miss a new study

Get alerted when new Recurrent T lymphoblastic lymphoma trials appear

Sign up with your email to follow new studies for Recurrent T lymphoblastic lymphoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Promising combo targets tough leukemia in early trial

Disease control Ongoing

This study tests a combination of two drugs—venetoclax and vincristine—in people with T-cell or B-cell acute lymphoblastic leukemia that has returned or not responded to prior treatment. The goal is to find the safest dose and see if the combo can lead to remission. About 40 adul…

Matched conditions: RECURRENT T LYMPHOBLASTIC LYMPHOMA

Phase 1/2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control

Last updated Aug 09, 2026 00:00 UTC

Recurrent T lymphoblastic lymphoma

Get alerted when new Recurrent T lymphoblastic lymphoma trials appear

Promising combo targets tough leukemia in early trial